Amgen Inc.
AMG.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$217.52B
Close$
Share Statistics
| Market cap | $217.52 Billion |
|---|---|
| Enterprise Value | $260.84 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 74.80% |
|---|---|
| Return on Assets | 9.14% |
| Return on Invested Capital | 18.48% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.85 |
| Enterprise Value to EBIT | 20.12 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 4.9 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About AMGEN Inc.
22,000 employees
CEO: Robert Bradway Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advan...